Phosphatidylinositol 3-kinase inhibitors
US9765060B2 · kind B2 · utility
13Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 2015 |
| Grant date | Sep 19, 2017 |
| Priority date | — |
| Expiry date | Jul 5, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/107
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides phosphatidylinositol 3-kinase (PI3K) inhibitors of formula (J),or pharmaceutically acceptable salts thereof, in which A, n, m, R1, R2, R3, R4, R5, R6 and R7 are as defined herein. These compounds are useful for treatment of conditions mediated by one or more PI3K isoforms. The present disclosure further provides pharmaceutical compositions that include a compound of formula (J), or pharmaceutically acceptable salts thereof, and methods of using these compounds and compositions to treat conditions mediated by one or more PI3K isoforms.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.